LCAR-B38M CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LCAR-B38M CAR-T cells, covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma [Phase 2]